KEAP1 and cancer: Increased NRF2 expression is a common event in cancer progression, which can be caused by constitutive transcriptional activation or a gain in gene copy number, but the increase in its protein level is usually caused by silencing, deletion, or mutation of its inhibitor Kelch-like ECH-associated protein 1 (KEAP1).